{"gene":"RALGDS","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1994,"finding":"RALGDS interacts directly with the GTP-bound (active) form of Ras p21 through the effector loop of Ras, competing with NF1 and Raf for binding to the effector loop; it does not interact with the GDP-bound form or effector-loop mutants of Ras.","method":"Yeast two-hybrid, in vitro binding with insect-cell-expressed proteins, co-immunoprecipitation, in vitro competition assay with NF1 GTPase-activating activity","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (yeast two-hybrid, in vitro binding, co-IP, competition assay) in a single foundational study; replicated by subsequent structural and biochemical studies","pmids":["7935463"],"is_preprint":false},{"year":1996,"finding":"Protein kinase A (PKA) phosphorylates RalGDS (without altering its GDP/GTP exchange activity for Ral) and also phosphorylates Raf-1 (reducing Raf-1 affinity for Ras), thereby selectively shifting Ras signaling from Raf toward RalGDS; EGF-induced Ras–RalGDS interaction in COS cells requires an intact effector loop on Ras.","method":"In vitro kinase phosphorylation assay, co-immunoprecipitation in COS cells, GDP/GTP exchange assay, use of effector-loop mutant Ras (T35A), forskolin treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay combined with cell-based co-IP and exchange assays; multiple orthogonal methods in one study","pmids":["8550624"],"is_preprint":false},{"year":1997,"finding":"RalGDS functions as an effector of Ras in cAMP-mediated (TSH-induced) growth stimulation in thyrocytes, downstream of Ras but independent of Raf-1/MEK; microinjection of dominant-negative RalA (which sequesters RalGDS family members) inhibited Ras- and cAMP-induced DNA synthesis.","method":"Yeast two-hybrid (identifies RalGDS as Ras effector-domain mutant V12G37 binding partner), co-immunoprecipitation in thyroid cell extracts, microinjection of dominant-negative RalA protein, DNA synthesis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus functional rescue by dominant-negative microinjection; multiple methods in one lab","pmids":["9038168"],"is_preprint":false},{"year":1997,"finding":"The three-dimensional structure of the Ras-interacting domain (RID) of RalGDS was determined; mutational analysis identified three residues in the RID critical for interaction with Ras.","method":"NMR structure determination; site-directed mutagenesis of RID residues, binding assays","journal":"Nature structural biology","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with mutagenesis validation","pmids":["9253406"],"is_preprint":false},{"year":1998,"finding":"Crystal structure of the Ras–RalGDS RID complex at 2.1 Å resolution revealed that the beta-sheet of the RID joins the switch I region of Ras to form an extended beta-sheet, and a second RID molecule contacts the switch II region of Ras, explaining cross-talk between Ras and Ral pathways and effector specificity.","method":"X-ray crystallography at 2.1 Å resolution","journal":"Nature structural biology","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with functional interpretation","pmids":["9628477"],"is_preprint":false},{"year":1998,"finding":"RalGDS (via a membrane-targeted CAAX construct) inhibits skeletal myogenesis independently of Raf, acting on SRF-dependent transcription; however, a Ras effector-loop mutant that retains RalGDS interaction (H-Ras G12V,E37G) also inhibits an SRF-independent myogenic reporter, indicating an additional Ras effector beyond RalGDS is required for full myogenic inhibition.","method":"Expression of constitutively active and dominant-negative constructs, luciferase reporter assays for muscle-specific promoters (alpha-actin-Luc, troponin I-Luc), co-expression in C3H10T1/2 cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — clean genetic and reporter assays; single lab but multiple constructs and reporters","pmids":["9651367"],"is_preprint":false},{"year":1999,"finding":"X-ray crystal structure of the Ras–RalGDS RBD complex confirmed inter-protein beta-sheet interaction via switch I; mutational analysis of interface residues quantified their contribution to binding affinity; gel filtration showed the complex is monomeric.","method":"X-ray crystallography, site-directed mutagenesis, gel filtration","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus mutagenesis and biophysical validation","pmids":["10371160"],"is_preprint":false},{"year":1999,"finding":"In C. elegans, the RalGEF ortholog (Rlf/RGL-1) is required for Ras-induced primitive endoderm differentiation of F9 embryonal carcinoma cells; constitutively active RalGEF (Rlf-CAAX) is sufficient to induce differentiation in a Ral-dependent manner that also requires basal MEK/ERK activity.","method":"Expression of constitutively active Rlf-CAAX and dominant-negative Ral, inhibitor of MEK (PD98059), differentiation morphology assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with dominant-negative and constitutively active constructs; single lab","pmids":["10442634"],"is_preprint":false},{"year":2001,"finding":"The Ras-binding domain (RBD) of RalGDS is important but not sufficient for Ras-stimulated Ral activation; an artificially membrane-targeted RalGDS lacking its RBD can still be activated by Ras via its switch II region (Y64W mutation in Ras impairs this). Rap1 blocks Ras-mediated RalGDS signaling only when RalGDS contains an intact RBD (by forming a long-lived competing complex), explaining Rap1 antagonism.","method":"In vivo Ral-GTP loading assay, point-mutation analysis (RBD-defective RalGDS, CAAX membrane targeting, Ras Y64W), kinetic analysis of complex formation by stopped-flow fluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinetic assays combined with cell-based Ral-GTP loading and multiple mutant analyses; multiple orthogonal methods","pmids":["11748241"],"is_preprint":false},{"year":2001,"finding":"JAK/STAT3 pathway activation induces RalGDS expression, and RalGDS expression leads to RalA activation in M1 myeloid leukemia cells; full RalA activation also requires Ras activity, revealing cross-talk between JAK/STAT3 and Ras/RalGDS/Ral pathways.","method":"Representational difference analysis to clone RalGDS, dominant-negative STAT3 expression, JAK inhibitor (JAB/SOCS1), Ras inhibitor, Ral-GTP pull-down assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis with dominant-negatives and inhibitors plus Ral-GTP pull-down; single lab","pmids":["11432872"],"is_preprint":false},{"year":2002,"finding":"Beta-arrestins bind RalGDS and maintain it in an inactive cytosolic complex; upon fMLP receptor stimulation, beta-arrestin–RalGDS complexes dissociate and both translocate to the plasma membrane, activating Ral signaling in a Ras-independent manner to mediate cytoskeletal reorganization; re-association of the complex inactivates Ral signaling.","method":"Yeast two-hybrid screening, co-immunoprecipitation from PMNs, subcellular fractionation/translocation assays, Ral-GTP activation assay","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by reciprocal co-IP from primary cells, translocation experiments with functional readout; multiple orthogonal methods","pmids":["12105416"],"is_preprint":false},{"year":2002,"finding":"PDK1 enhances RalGDS catalytic (GEF) activity in a kinase-independent manner: the non-catalytic N-terminus of PDK1 forms an EGF-induced complex with the N-terminus of RalGDS, relieving its autoinhibitory effect on the catalytic domain, thereby providing a second mechanism (beyond Ras-mediated membrane redistribution) for Ral-GEF activation.","method":"Co-immunoprecipitation, dominant-negative PDK1 kinase-dead mutant, deletion mapping of PDK1–RalGDS interaction domains, in vivo Ral-GTP assay, EGF stimulation","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — kinase-dead mutant distinguishes catalytic from scaffolding function; domain mapping plus functional GTP-loading assay; multiple methods","pmids":["11889038"],"is_preprint":false},{"year":2002,"finding":"RalGDS mediates Ras-dependent activation of ATF2 Thr69 phosphorylation via a RalGDS–Src–p38 pathway, while Raf–MEK–ERK phosphorylates ATF2 Thr71; cooperation of both pathways is required for full ATF2 activation by growth factors.","method":"Ras effector-loop mutants (G12V/G37 selectively activates RalGEF path), dominant-negative constructs, phospho-specific antibodies for ATF2 Thr69/Thr71, in vivo kinase assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with well-characterized effector-loop mutants plus quantitative phosphorylation readout; independently consistent with known pathway","pmids":["12110590"],"is_preprint":false},{"year":2002,"finding":"RalGDS and PI3K (but not Raf) mediate Ras-dependent activation of choline kinase; RalGDS and PI3K also provide opposing regulatory inputs to phospholipase D downstream of oncogenic Ras.","method":"Ras effector-domain mutants (G12V/S35 Raf-only, G12V/C40 PI3K-only, G12V/G37 RalGEF-only), choline kinase activity assay, phospholipase D activity assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — well-validated effector-domain mutant approach; single lab but two different enzymatic readouts","pmids":["11840339"],"is_preprint":false},{"year":2004,"finding":"The Ras/RalGEF/p38 pathway is required for reovirus oncolysis: Ras mutant V12G37 (which signals only through RalGEFs) supports reovirus infection; dominant-negative RalA blocks infection; chemical inhibition of p38 (but not JNK) prevents reovirus replication in Ras-transformed cells.","method":"NIH 3T3 cells expressing Ras effector-domain mutants, activated RalGEF (Rlf) expression, dominant-negative RalA, p38 and JNK chemical inhibitors, reovirus replication assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — epistasis via effector-domain mutants, dominant-negative, and pharmacological inhibitors with clear viral replication readout","pmids":["15263068"],"is_preprint":false},{"year":2004,"finding":"RalGDS mediates Ras-induced upregulation of ST6Gal I (beta-galactoside alpha2,6-sialyltransferase) via the RalGEF signal, specifically through the housekeeping promoter P3; this was shown using Ras effector-domain mutants that selectively activate individual Ras pathways.","method":"Ras effector-domain mutants (H-RasV12S35, H-RasV12C40, H-RasV12G37), RT-PCR, sialyltransferase activity assay, 5'-RACE, inducible H-RasV12 expression system","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — selective effector-domain mutants with multiple readouts (mRNA, enzyme activity, cell-surface glycan); single lab","pmids":["15355339"],"is_preprint":false},{"year":2005,"finding":"RalGDS knockout mice are viable and develop normally but show markedly reduced tumor incidence, size, and malignant progression in Ras-driven multistage skin carcinogenesis; RalGDS controls survival (via the JNK/SAPK pathway) rather than proliferation of transformed cells.","method":"Ralgds knockout mice, DMBA/TPA skin carcinogenesis model, cell proliferation assays, cell survival/apoptosis assays, JNK/SAPK pathway analysis in tumor-derived cells","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic KO with well-defined tumor phenotype and pathway analysis; strong evidence from a landmark study","pmids":["15766660"],"is_preprint":false},{"year":2007,"finding":"Activation of the RalGEF pathway (but not Raf/ERK or PI3K) promotes prostate cancer bone metastasis; loss of RalA in metastatic PC3 cells inhibits bone metastasis but not subcutaneous tumor growth, implicating Ral-dependent expansion in the bone microenvironment.","method":"Ras effector-domain mutants expressed in DU145 cells, in vivo bone metastasis model, RalA shRNA knockdown in PC3 cells, intracardiac injection metastasis assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — in vivo epistasis with effector-domain mutants and RalA knockdown; clear organ-specific metastasis readout","pmids":["17709381"],"is_preprint":false},{"year":2008,"finding":"RalGDS promotes Akt phosphorylation by PDK1 through a second, GEF-independent scaffolding function: RalGDS brings PDK1 (via its N-terminus) and Akt (via its central region, through intermediary JIP1) together; suppression of RalGDS blocks EGF- and insulin-induced Akt phosphorylation and inhibits cell proliferation.","method":"Co-immunoprecipitation, RNAi knockdown of RalGDS, deletion mutants of RalGDS separating GEF activity from Akt activation, phospho-Akt immunoblot, proliferation assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — domain separation mutants plus RNAi with two orthogonal functional readouts (phospho-Akt and proliferation); single lab but rigorous","pmids":["18285454"],"is_preprint":false},{"year":2008,"finding":"RalGDS mediates exocytosis of Weibel-Palade bodies (WPBs) from endothelial cells: RNAi knockdown of RalGDS inhibits thrombin- and epinephrine-induced WPB exocytosis; overexpression promotes it; a GEF-dead RalGDS acts as dominant negative. RalGDS binds calmodulin (CaM) via an N-terminal CaM-binding domain, and this CaM association is required for Ral activation and WPB exocytosis.","method":"RNAi knockdown, overexpression, dominant-negative GEF-dead RalGDS, cell-permeable CaM-binding domain peptide, Ral-GTP pull-down, WPB exocytosis (VWF release) assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic manipulations (RNAi, OE, dominant-negative) with clear functional readout plus identification of calmodulin as binding partner by peptide inhibitor","pmids":["18417737"],"is_preprint":false},{"year":2013,"finding":"RalGDS-null cardiomyocytes show impaired load-induced autophagy and blunted hypertrophic growth in response to pressure overload (TAC); specifically RalB (downstream of RalGDS) is required for mTOR-dependent cardiomyocyte autophagy, linking RalGDS to exocyst-dependent membrane trafficking in cardiac remodeling.","method":"Ralgds knockout mice, TAC pressure-overload model, RalA/RalB siRNA knockdown in neonatal rat cardiomyocytes, autophagy markers (LC3, beclin), echocardiography","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo KO plus cell-based siRNA with defined autophagy readout; single lab","pmids":["23473774"],"is_preprint":false},{"year":2015,"finding":"RILP (Rab7-interacting lysosomal protein) interacts with the GEF domain of RalGDS through RILP's N-terminal region, recruits RalGDS to late endosomal compartments, and inhibits RalGDS GEF activity toward RalA, thereby suppressing breast cancer cell invasion.","method":"Co-immunoprecipitation, truncation/domain mapping, immunofluorescence microscopy, RalA-GTP pull-down, Matrigel invasion assay, RNAi knockdown","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP with domain mapping plus subcellular localization and functional GEF-activity assay; single lab","pmids":["26469971"],"is_preprint":false},{"year":2017,"finding":"Single-molecule fluorescence imaging showed that RalGDS translocates from the cytoplasm to the plasma membrane upon EGF-induced Ras activation via its RBD (not the REMCDC catalytic domain); the REMCDC domain reduces the dissociation rate from the membrane after Ras activation or Ral hyperexpression; RalGDS clusters at the membrane and the Y64 residue of Ras participates in stabilizing the RalGDS–membrane interaction.","method":"Single-molecule total internal reflection fluorescence (TIRF) microscopy in living HeLa cells, EGF stimulation, domain deletion mutants (RBD vs. REMCDC), kinetic analysis of membrane association/dissociation","journal":"Biophysics and physicobiology","confidence":"Medium","confidence_rationale":"Tier 2 — direct single-molecule localization with functional domain analysis; single lab but novel orthogonal method","pmids":["28744424"],"is_preprint":false},{"year":2019,"finding":"In C. elegans, the RalGDS ortholog RGL-1 has two genetically separable activities: a canonical GEF-dependent activity that activates RAL-1 to promote 2° vulval cell fate, and a non-canonical GEF-independent activity that promotes 1° fate via the PI3K-PDK-1-AKT cascade; these opposing activities reduce developmental stochasticity.","method":"C. elegans genetics, RGL-1 deletion and domain mutants, epistasis with dominant-negative and activated pathway components, vulval cell fate scoring","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 — rigorous genetic epistasis in a model organism; C. elegans ortholog with conserved domain architecture","pmids":["31086367"],"is_preprint":false}],"current_model":"RALGDS is a Ras effector and guanine nucleotide exchange factor (GEF) for Ral GTPases (RalA and RalB): upon growth factor stimulation, GTP-loaded Ras binds the RBD of RALGDS (via an inter-protein beta-sheet with Ras switch I, as revealed by crystal structures), recruiting RALGDS to the plasma membrane and relieving autoinhibition of its CDC25 catalytic domain; PDK1 further enhances RALGDS GEF activity through a kinase-independent scaffolding interaction; beta-arrestins additionally regulate RALGDS by sequestering it in the cytosol and chaperoning its membrane translocation; activated Ral then drives cytoskeletal reorganization, Weibel-Palade body exocytosis, autophagy, and stress-kinase (JNK/p38) signaling, while RALGDS also scaffolds PDK1–Akt to promote cell survival, making it a multifunctional node in Ras-dependent oncogenesis."},"narrative":{"teleology":[{"year":1994,"claim":"Establishing that RALGDS is a direct, GTP-dependent effector of Ras resolved how the Ral-GEF pathway connects to the canonical Ras switch and competes with Raf and NF1 for the Ras effector loop.","evidence":"Yeast two-hybrid, in vitro binding, co-immunoprecipitation, and NF1-competition assay with insect-cell-expressed proteins","pmids":["7935463"],"confidence":"High","gaps":["Structural basis of the Ras–RalGDS interaction was unknown","In vivo relevance of the Ras–RalGDS axis was not yet tested","How GEF activity is regulated beyond Ras binding was unclear"]},{"year":1996,"claim":"Demonstration that PKA phosphorylates Raf-1 to reduce its Ras affinity without affecting RalGDS exchange activity revealed a signal-switching mechanism that reroutes Ras output from Raf toward RalGDS under cAMP-elevating conditions.","evidence":"In vitro kinase assay, co-immunoprecipitation in COS cells, GDP/GTP exchange assay, Ras T35A effector-loop mutant, forskolin treatment","pmids":["8550624"],"confidence":"High","gaps":["Whether PKA-mediated pathway switching operates in physiological tissues was untested","Direct phosphorylation sites on RalGDS were not mapped"]},{"year":1997,"claim":"NMR structure of the RalGDS Ras-interacting domain and demonstration that RalGDS mediates Ras-dependent, Raf-independent proliferation in thyrocytes established the structural and functional autonomy of the Ras–RalGDS arm.","evidence":"NMR structure determination with mutagenesis; dominant-negative RalA microinjection blocking cAMP/Ras-induced DNA synthesis in thyroid cells","pmids":["9253406","9038168"],"confidence":"High","gaps":["Full atomic detail of the Ras–RalGDS complex was still lacking","Downstream targets of RalA activation in this context were unidentified"]},{"year":1998,"claim":"Crystal structures of the Ras–RalGDS RBD complex at 2.1 Å revealed an inter-protein β-sheet mediated by Ras switch I, providing the atomic framework for understanding effector selectivity among Ras targets.","evidence":"X-ray crystallography at 2.1 Å resolution, confirmed by independent structure with mutagenesis and gel filtration (1999)","pmids":["9628477","10371160"],"confidence":"High","gaps":["How the catalytic CDC25 domain is autoinhibited and activated was unresolved","Role of the Ras switch II contact observed in the crystal remained functionally untested"]},{"year":2001,"claim":"Dissection of RBD-dependent versus RBD-independent activation mechanisms showed that membrane recruitment via the RBD is important but not sufficient, and that Rap1 antagonizes RalGDS by sequestering the RBD in a kinetically trapped complex, resolving a long-standing question about Rap1–Ras cross-talk.","evidence":"In vivo Ral-GTP loading with RBD-defective/CAAX-targeted RalGDS, Ras Y64W mutant, stopped-flow fluorescence kinetics","pmids":["11748241"],"confidence":"High","gaps":["Identity of the non-RBD Ras contact site on RalGDS was not mapped","Whether Rap1 antagonism operates in vivo was unconfirmed"]},{"year":2002,"claim":"Multiple studies in 2002 established that RalGDS integrates diverse regulatory inputs (PDK1 scaffolding, beta-arrestin sequestration) and diverse outputs (ATF2 via Src/p38, choline kinase, Ral-driven cytoskeletal reorganization), positioning it as a multifunctional signaling hub rather than a simple Ras-to-Ral relay.","evidence":"PDK1 kinase-dead mutant co-IP and domain mapping with Ral-GTP assay; beta-arrestin yeast two-hybrid, co-IP from PMNs, translocation assays; Ras effector-domain mutant epistasis for ATF2 phosphorylation and choline kinase activity","pmids":["11889038","12105416","12110590","11840339"],"confidence":"High","gaps":["Whether PDK1 scaffolding and beta-arrestin regulation converge on the same pool of RalGDS was unknown","Structural basis of autoinhibition relief by PDK1 was not determined"]},{"year":2005,"claim":"RALGDS knockout mice showed reduced tumor incidence and impaired JNK-dependent survival of transformed cells in a Ras-driven carcinogenesis model, providing the first in vivo genetic proof that RALGDS is essential for Ras-mediated oncogenesis.","evidence":"Ralgds-null mice subjected to DMBA/TPA multistage skin carcinogenesis, with tumor burden quantification, apoptosis assays, and JNK pathway analysis","pmids":["15766660"],"confidence":"High","gaps":["Whether RalGDS is required for tumor maintenance versus initiation was not distinguished","Contribution of individual Ral isoforms (RalA vs RalB) in vivo was not resolved"]},{"year":2007,"claim":"The RalGEF pathway was shown to specifically promote bone metastasis of prostate cancer cells through RalA, distinct from subcutaneous tumor growth, establishing tissue-microenvironment specificity for RalGDS signaling.","evidence":"Ras effector-domain mutants in DU145 cells, RalA shRNA in PC3 cells, intracardiac injection metastasis model","pmids":["17709381"],"confidence":"High","gaps":["Bone microenvironment signals activating RalGDS were not identified","Whether RalB also contributes to metastasis in this model was not tested"]},{"year":2008,"claim":"Discovery that RALGDS scaffolds PDK1 and Akt (via JIP1) to promote Akt phosphorylation independently of its GEF activity, and that it drives Weibel-Palade body exocytosis through calmodulin-dependent Ral activation, revealed two additional non-canonical functions separable from Ral exchange.","evidence":"Domain-separation mutants and RNAi for PDK1–Akt scaffolding with phospho-Akt readout; RNAi, dominant-negative GEF-dead RalGDS, CaM-binding domain peptide for WPB exocytosis (VWF release)","pmids":["18285454","18417737"],"confidence":"High","gaps":["Whether JIP1 is the sole mediator of Akt recruitment was not confirmed","Calmodulin-binding site on RalGDS was mapped only by peptide competition, not structurally"]},{"year":2013,"claim":"RALGDS-null cardiomyocytes showed impaired autophagy and blunted hypertrophic growth under pressure overload, linking RALGDS–RalB signaling to mTOR-dependent autophagy and cardiac stress adaptation beyond oncogenesis.","evidence":"Ralgds knockout mice with TAC pressure-overload, RalA/RalB siRNA in neonatal cardiomyocytes, autophagy markers (LC3, beclin), echocardiography","pmids":["23473774"],"confidence":"Medium","gaps":["Exocyst-dependent membrane trafficking mechanism in cardiomyocytes was inferred but not directly demonstrated","Whether RalGDS GEF or scaffolding activity mediates the cardiac phenotype was not distinguished"]},{"year":2015,"claim":"RILP was identified as a negative regulator that recruits RalGDS to late endosomes and inhibits its GEF activity, suppressing RalA-dependent breast cancer cell invasion and revealing compartment-specific regulation of RalGDS.","evidence":"Co-immunoprecipitation, domain mapping, immunofluorescence, RalA-GTP pull-down, Matrigel invasion assay","pmids":["26469971"],"confidence":"Medium","gaps":["Whether RILP-mediated endosomal sequestration operates in non-transformed cells was not tested","Structural basis of RILP inhibition of the GEF domain was not resolved"]},{"year":2017,"claim":"Single-molecule imaging directly visualized RalGDS membrane recruitment kinetics, showing that the RBD mediates initial Ras-dependent translocation while the REMCDC catalytic domain reduces dissociation rate, providing a biophysical framework for two-step membrane engagement.","evidence":"Single-molecule TIRF microscopy in living HeLa cells with domain deletion mutants and EGF stimulation","pmids":["28744424"],"confidence":"Medium","gaps":["Whether membrane clustering reflects oligomerization or lipid-domain partitioning was not resolved","Kinetic measurements were in a single overexpression system"]},{"year":2019,"claim":"Genetic analysis in C. elegans demonstrated that the RalGDS ortholog RGL-1 has genetically separable GEF-dependent (promoting Ral-mediated 2° fate) and GEF-independent (promoting PI3K–PDK-1–AKT-mediated 1° fate) activities, confirming evolutionary conservation of dual signaling modes.","evidence":"C. elegans RGL-1 deletion and domain mutants, genetic epistasis with pathway components, vulval fate scoring","pmids":["31086367"],"confidence":"Medium","gaps":["Whether the mammalian GEF-independent PDK1–Akt scaffolding function is fully orthologous to the worm pathway was not tested","Direct biochemical interaction between RGL-1 and worm PDK-1 was not demonstrated"]},{"year":null,"claim":"A full structural model of autoinhibited full-length RALGDS, the conformational change upon PDK1 or Ras engagement, and the relative quantitative contributions of GEF-dependent versus scaffolding functions in specific disease contexts remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length RALGDS structure exists","Quantitative partitioning of GEF versus scaffolding functions in vivo is unknown","Whether therapeutic targeting of the RBD–Ras interface is feasible has not been explored structurally"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2,8,11,19]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[18,23]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[10,22]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[10,22]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[21]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,4,8,11,12]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[16,17]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[20]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[19]}],"complexes":[],"partners":["HRAS","RALA","RALB","PDPK1","ARRB1","ARRB2","RILP","CALM1"],"other_free_text":[]},"mechanistic_narrative":"RALGDS is a guanine nucleotide exchange factor (GEF) for Ral GTPases (RalA and RalB) and a direct effector of Ras, serving as a critical signaling node that translates Ras activation into cytoskeletal reorganization, regulated exocytosis, autophagy, stress-kinase signaling, and cell survival. GTP-loaded Ras recruits RALGDS to the plasma membrane through an inter-protein β-sheet interaction between Ras switch I and the RALGDS Ras-binding domain (RBD), while PDK1 relieves autoinhibition of the catalytic CDC25 domain in a kinase-independent manner, and beta-arrestins regulate RALGDS cytosol-to-membrane translocation upon GPCR stimulation [PMID:9628477, PMID:11889038, PMID:12105416]. Beyond its GEF activity, RALGDS scaffolds PDK1 and Akt (via JIP1) to promote Akt phosphorylation and cell survival independently of Ral exchange, and signals through Ral to JNK/p38 and Src to control ATF2 phosphorylation and tumor cell survival [PMID:18285454, PMID:12110590, PMID:15766660]. RALGDS knockout mice are viable but show markedly reduced Ras-driven tumor incidence and impaired load-induced cardiac autophagy, establishing RALGDS as essential for Ras-dependent oncogenesis and stress-responsive membrane trafficking in vivo [PMID:15766660, PMID:23473774]."},"prefetch_data":{"uniprot":{"accession":"Q12967","full_name":"Ral guanine nucleotide dissociation stimulator","aliases":["Ral guanine nucleotide exchange factor","RalGEF"],"length_aa":914,"mass_kda":100.6,"function":"Functions as a guanine nucleotide exchange factor (GEF) activating either RalA or RalB GTPases and plays an important role in intracellular transport. Interacts and acts as an effector molecule for R-Ras, H-Ras, K-Ras, and Rap (By similarity). During bacterial clearance, recognizes 'Lys-33'-linked polyubiquitinated TRAF3 and subsequently mediates assembly of the exocyst complex (PubMed:27438768)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q12967/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RALGDS","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RALGDS","total_profiled":1310},"omim":[{"mim_id":"616743","title":"RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 3; RGL3","url":"https://www.omim.org/entry/616743"},{"mim_id":"612214","title":"RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 4; RGL4","url":"https://www.omim.org/entry/612214"},{"mim_id":"609592","title":"RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 2; RIT2","url":"https://www.omim.org/entry/609592"},{"mim_id":"609591","title":"RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 1; RIT1","url":"https://www.omim.org/entry/609591"},{"mim_id":"605801","title":"RALA-BINDING PROTEIN 1; RALBP1","url":"https://www.omim.org/entry/605801"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Nucleoplasm","reliability":"Uncertain"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RALGDS"},"hgnc":{"alias_symbol":["RGF","RalGEF","RGDS"],"prev_symbol":[]},"alphafold":{"accession":"Q12967","domains":[{"cath_id":"-","chopping":"44-52_61-88_107-120","consensus_level":"medium","plddt":66.8627,"start":44,"end":120},{"cath_id":"1.20.870.10","chopping":"121-168_190-249","consensus_level":"medium","plddt":84.7077,"start":121,"end":249},{"cath_id":"1.10.840.10","chopping":"386-542_560-646","consensus_level":"high","plddt":90.3537,"start":386,"end":646},{"cath_id":"3.10.20.90","chopping":"800-883","consensus_level":"high","plddt":85.3212,"start":800,"end":883}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q12967","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q12967-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q12967-F1-predicted_aligned_error_v6.png","plddt_mean":62.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RALGDS","jax_strain_url":"https://www.jax.org/strain/search?query=RALGDS"},"sequence":{"accession":"Q12967","fasta_url":"https://rest.uniprot.org/uniprotkb/Q12967.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q12967/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q12967"}},"corpus_meta":[{"pmid":"12850155","id":"PMC_12850155","title":"Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.","date":"2003","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12850155","citation_count":952,"is_preprint":false},{"pmid":"7935463","id":"PMC_7935463","title":"ralGDS family members interact with the effector loop of ras p21.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7935463","citation_count":253,"is_preprint":false},{"pmid":"9628477","id":"PMC_9628477","title":"Structural basis for the interaction of Ras with RalGDS.","date":"1998","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/9628477","citation_count":220,"is_preprint":false},{"pmid":"12110590","id":"PMC_12110590","title":"Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12110590","citation_count":185,"is_preprint":false},{"pmid":"15263068","id":"PMC_15263068","title":"Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15263068","citation_count":158,"is_preprint":false},{"pmid":"15766660","id":"PMC_15766660","title":"RalGDS is required for tumor formation in a model of skin carcinogenesis.","date":"2005","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/15766660","citation_count":141,"is_preprint":false},{"pmid":"16768407","id":"PMC_16768407","title":"Presentation of RGDS epitopes on self-assembled nanofibers of branched peptide amphiphiles.","date":"2006","source":"Biomacromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/16768407","citation_count":119,"is_preprint":false},{"pmid":"8710374","id":"PMC_8710374","title":"RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8710374","citation_count":117,"is_preprint":false},{"pmid":"12105416","id":"PMC_12105416","title":"Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization.","date":"2002","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12105416","citation_count":112,"is_preprint":false},{"pmid":"15003013","id":"PMC_15003013","title":"Temperature-responsive cell culture surfaces enable \"on-off\" affinity control between cell integrins and RGDS ligands.","date":"2004","source":"Biomacromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/15003013","citation_count":103,"is_preprint":false},{"pmid":"16290119","id":"PMC_16290119","title":"Covalent immobilization of RGDS on hydrogel surfaces to direct cell alignment and migration.","date":"2005","source":"Journal of controlled release : official journal of the Controlled Release Society","url":"https://pubmed.ncbi.nlm.nih.gov/16290119","citation_count":102,"is_preprint":false},{"pmid":"11840339","id":"PMC_11840339","title":"Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11840339","citation_count":102,"is_preprint":false},{"pmid":"2191722","id":"PMC_2191722","title":"Elegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor.","date":"1990","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/2191722","citation_count":94,"is_preprint":false},{"pmid":"7517944","id":"PMC_7517944","title":"Activation of the alpha 4 beta 1 integrin through the beta 1 subunit induces recognition of the RGDS sequence in fibronectin.","date":"1994","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7517944","citation_count":92,"is_preprint":false},{"pmid":"17709381","id":"PMC_17709381","title":"Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17709381","citation_count":89,"is_preprint":false},{"pmid":"10371160","id":"PMC_10371160","title":"Structural and biochemical analysis of Ras-effector signaling via RalGDS.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10371160","citation_count":89,"is_preprint":false},{"pmid":"21779498","id":"PMC_21779498","title":"The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery.","date":"2011","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21779498","citation_count":88,"is_preprint":false},{"pmid":"1793678","id":"PMC_1793678","title":"RGDS tetrapeptide binds to osteoblasts and inhibits fibronectin-mediated adhesion.","date":"1991","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/1793678","citation_count":81,"is_preprint":false},{"pmid":"3611194","id":"PMC_3611194","title":"Fibroblast adhesion to RGDS shows novel features compared with fibronectin.","date":"1987","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/3611194","citation_count":76,"is_preprint":false},{"pmid":"9253406","id":"PMC_9253406","title":"Three-dimensional structure of the Ras-interacting domain of RalGDS.","date":"1997","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/9253406","citation_count":72,"is_preprint":false},{"pmid":"1737795","id":"PMC_1737795","title":"Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1737795","citation_count":68,"is_preprint":false},{"pmid":"9038168","id":"PMC_9038168","title":"RalGDS functions in Ras- and cAMP-mediated growth stimulation.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9038168","citation_count":66,"is_preprint":false},{"pmid":"10876238","id":"PMC_10876238","title":"Pressure-induced local unfolding of the Ras binding domain of RalGDS.","date":"2000","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/10876238","citation_count":66,"is_preprint":false},{"pmid":"20478380","id":"PMC_20478380","title":"RalGDS family members couple Ras to Ral signalling and that's not all.","date":"2010","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/20478380","citation_count":65,"is_preprint":false},{"pmid":"8550624","id":"PMC_8550624","title":"Regulation of interaction of ras p21 with RalGDS and Raf-1 by cyclic AMP-dependent protein kinase.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8550624","citation_count":65,"is_preprint":false},{"pmid":"7629143","id":"PMC_7629143","title":"The cDNA sequence of human endothelial cell multimerin. A unique protein with RGDS, coiled-coil, and epidermal growth factor-like domains and a carboxyl terminus similar to the globular domain of complement C1q and collagens type VIII and X.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7629143","citation_count":64,"is_preprint":false},{"pmid":"19272161","id":"PMC_19272161","title":"Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways.","date":"2009","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/19272161","citation_count":62,"is_preprint":false},{"pmid":"11889038","id":"PMC_11889038","title":"PDK1 mediates growth factor-induced Ral-GEF activation by a kinase-independent mechanism.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11889038","citation_count":59,"is_preprint":false},{"pmid":"20964430","id":"PMC_20964430","title":"Vibrational Stark effect spectroscopy at the interface of Ras and Rap1A bound to the Ras binding domain of RalGDS reveals an electrostatic mechanism for protein-protein interaction.","date":"2010","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/20964430","citation_count":58,"is_preprint":false},{"pmid":"8939933","id":"PMC_8939933","title":"Identification of a novel RalGDS-related protein as a candidate effector for Ras and Rap1.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8939933","citation_count":56,"is_preprint":false},{"pmid":"8631600","id":"PMC_8631600","title":"Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lungs followed by extravasation.","date":"1996","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8631600","citation_count":56,"is_preprint":false},{"pmid":"12734821","id":"PMC_12734821","title":"Adhesion and migration of marrow-derived osteoblasts on injectable in situ crosslinkable poly(propylene fumarate-co-ethylene glycol)-based hydrogels with a covalently linked RGDS peptide.","date":"2003","source":"Journal of biomedical materials research. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/12734821","citation_count":56,"is_preprint":false},{"pmid":"2544438","id":"PMC_2544438","title":"Mechanism of fibronectin-mediated cell migration: dependence or independence of cell migration susceptibility on RGDS-directed receptor (integrin).","date":"1989","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/2544438","citation_count":56,"is_preprint":false},{"pmid":"14982875","id":"PMC_14982875","title":"RGDS peptide induces caspase 8 and caspase 9 activation in human endothelial cells.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/14982875","citation_count":55,"is_preprint":false},{"pmid":"7814401","id":"PMC_7814401","title":"Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7814401","citation_count":55,"is_preprint":false},{"pmid":"11953380","id":"PMC_11953380","title":"rgf encodes a novel two-component signal transduction system of Streptococcus agalactiae.","date":"2002","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11953380","citation_count":54,"is_preprint":false},{"pmid":"10869344","id":"PMC_10869344","title":"A novel RalGEF-like protein, RGL3, as a candidate effector for rit and Ras.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10869344","citation_count":52,"is_preprint":false},{"pmid":"2966069","id":"PMC_2966069","title":"Ganglioside-dependent adhesion events of human neuroblastoma cells regulated by the RGDS-dependent fibronectin receptor and proteoglycans.","date":"1988","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/2966069","citation_count":52,"is_preprint":false},{"pmid":"2212000","id":"PMC_2212000","title":"Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration into the rabbit lung. A potential mechanism for C5 fragment-induced monocyte lung accumulation.","date":"1990","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/2212000","citation_count":51,"is_preprint":false},{"pmid":"20019343","id":"PMC_20019343","title":"The integrin-blocking peptide RGDS inhibits airway smooth muscle remodeling in a guinea pig model of allergic asthma.","date":"2009","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20019343","citation_count":50,"is_preprint":false},{"pmid":"15355339","id":"PMC_15355339","title":"Ras oncogene induces beta-galactoside alpha2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter.","date":"2004","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15355339","citation_count":49,"is_preprint":false},{"pmid":"18417737","id":"PMC_18417737","title":"Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cells.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18417737","citation_count":45,"is_preprint":false},{"pmid":"8476793","id":"PMC_8476793","title":"Cell-attachment activities of surface immobilized oligopeptides RGD, RGDS, RGDV, RGDT, and YIGSR toward five cell lines.","date":"1993","source":"Journal of biomaterials science. Polymer edition","url":"https://pubmed.ncbi.nlm.nih.gov/8476793","citation_count":45,"is_preprint":false},{"pmid":"28087486","id":"PMC_28087486","title":"Enhanced articular cartilage by human mesenchymal stem cells in enzymatically mediated transiently RGDS-functionalized collagen-mimetic hydrogels.","date":"2017","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/28087486","citation_count":44,"is_preprint":false},{"pmid":"9651367","id":"PMC_9651367","title":"A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9651367","citation_count":43,"is_preprint":false},{"pmid":"20643479","id":"PMC_20643479","title":"Effects of RGDS sequence genetically interfused in the silk fibroin light chain protein on chondrocyte adhesion and cartilage synthesis.","date":"2010","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/20643479","citation_count":42,"is_preprint":false},{"pmid":"11748241","id":"PMC_11748241","title":"The activation of RalGDS can be achieved independently of its Ras binding domain. Implications of an activation mechanism in Ras effector specificity and signal distribution.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11748241","citation_count":42,"is_preprint":false},{"pmid":"11788587","id":"PMC_11788587","title":"Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11788587","citation_count":41,"is_preprint":false},{"pmid":"2951267","id":"PMC_2951267","title":"A second cell-binding domain on fibronectin (RGDS-independent) for neurite extension of human neuroblastoma cells.","date":"1987","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/2951267","citation_count":41,"is_preprint":false},{"pmid":"17503524","id":"PMC_17503524","title":"RGDS peptides immobilized on titanium alloy stimulate bone cell attachment, differentiation and confer resistance to apoptosis.","date":"2007","source":"Journal of biomedical materials research. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/17503524","citation_count":39,"is_preprint":false},{"pmid":"22619531","id":"PMC_22619531","title":"RGDS-functionalized polyethylene glycol hydrogel-coated magnetic iron oxide nanoparticles enhance specific intracellular uptake by HeLa cells.","date":"2012","source":"International journal of nanomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/22619531","citation_count":38,"is_preprint":false},{"pmid":"1724445","id":"PMC_1724445","title":"Synthesis and cell attachment activity of bioactive oligopeptides: RGD, RGDS, RGDV, and RGDT.","date":"1991","source":"Journal of biomedical materials research","url":"https://pubmed.ncbi.nlm.nih.gov/1724445","citation_count":37,"is_preprint":false},{"pmid":"18285454","id":"PMC_18285454","title":"RalGDS couples growth factor signaling to Akt activation.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18285454","citation_count":36,"is_preprint":false},{"pmid":"17697986","id":"PMC_17697986","title":"Evaluation of L929 fibroblast attachment and proliferation on Arg-Gly-Asp-Ser (RGDS)-immobilized chitosan in serum-containing/serum-free cultures.","date":"2007","source":"Journal of bioscience and bioengineering","url":"https://pubmed.ncbi.nlm.nih.gov/17697986","citation_count":33,"is_preprint":false},{"pmid":"12824296","id":"PMC_12824296","title":"Arg-Gly-Asp-Ser (RGDS) peptide stimulates transforming growth factor beta1 transcription and secretion through integrin activation.","date":"2003","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12824296","citation_count":32,"is_preprint":false},{"pmid":"25856240","id":"PMC_25856240","title":"Distinct sensitivities to phosphate deprivation suggest that RGF peptides play disparate roles in Arabidopsis thaliana root development.","date":"2015","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/25856240","citation_count":30,"is_preprint":false},{"pmid":"20412563","id":"PMC_20412563","title":"Intracellular targets of RGDS peptide in melanoma cells.","date":"2010","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20412563","citation_count":29,"is_preprint":false},{"pmid":"2968824","id":"PMC_2968824","title":"Glycoprotein IIb-IIIa and RGD(S) are not important for fibronectin-dependent platelet adhesion under flow conditions.","date":"1988","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/2968824","citation_count":29,"is_preprint":false},{"pmid":"32481893","id":"PMC_32481893","title":"The bioactivity of composite Fmoc-RGDS-collagen gels.","date":"2014","source":"Biomaterials science","url":"https://pubmed.ncbi.nlm.nih.gov/32481893","citation_count":28,"is_preprint":false},{"pmid":"10442634","id":"PMC_10442634","title":"Interdependent action of RalGEF and Erk in Ras-induced primitive endoderm differentiation of F9 embryonal carcinoma cells.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10442634","citation_count":27,"is_preprint":false},{"pmid":"8509226","id":"PMC_8509226","title":"Interaction of human malignant melanoma tumor spheroids with endothelium and reconstituted basement membrane: modulation by RGDS.","date":"1993","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8509226","citation_count":26,"is_preprint":false},{"pmid":"9300641","id":"PMC_9300641","title":"RGDS tetrapeptide and hippocampal in vitro kindling in rats: evidence for integrin-mediated physiological stability.","date":"1997","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/9300641","citation_count":25,"is_preprint":false},{"pmid":"26097013","id":"PMC_26097013","title":"Soft PEG-Hydrogels with Independently Tunable Stiffness and RGDS-Content for Cell Adhesion Studies.","date":"2015","source":"Macromolecular bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/26097013","citation_count":24,"is_preprint":false},{"pmid":"2349083","id":"PMC_2349083","title":"The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDS.","date":"1990","source":"Nouvelle revue francaise d'hematologie","url":"https://pubmed.ncbi.nlm.nih.gov/2349083","citation_count":23,"is_preprint":false},{"pmid":"33901628","id":"PMC_33901628","title":"Root meristem growth factor RGF, a sulfated peptide hormone in plants.","date":"2021","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/33901628","citation_count":22,"is_preprint":false},{"pmid":"16565960","id":"PMC_16565960","title":"Effects of CD44 antibody-- or RGDS peptide--immobilized magnetic beads on cell proliferation and chondrogenesis of mesenchymal stem cells.","date":"2006","source":"Journal of biomedical materials research. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/16565960","citation_count":22,"is_preprint":false},{"pmid":"2005585","id":"PMC_2005585","title":"Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).","date":"1991","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/2005585","citation_count":21,"is_preprint":false},{"pmid":"2084945","id":"PMC_2084945","title":"Synthetic RGDS-containing peptides of von Willebrand factor inhibit platelet adhesion to collagen.","date":"1990","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/2084945","citation_count":21,"is_preprint":false},{"pmid":"27428386","id":"PMC_27428386","title":"RGDS- and TAT-Conjugated Upconversion of NaYF4:Yb(3+)/Er(3+)&SiO2 Nanoparticles: In Vitro Human Epithelioid Cervix Carcinoma Cellular Uptake, Imaging, and Targeting.","date":"2016","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/27428386","citation_count":20,"is_preprint":false},{"pmid":"27484779","id":"PMC_27484779","title":"Control of fibrotic changes through the synergistic effects of anti-fibronectin antibody and an RGDS-tagged form of the same antibody.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27484779","citation_count":19,"is_preprint":false},{"pmid":"22738401","id":"PMC_22738401","title":"Role of electrostatics in differential binding of RalGDS to Rap mutations E30D and K31E investigated by vibrational spectroscopy of thiocyanate probes.","date":"2012","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/22738401","citation_count":19,"is_preprint":false},{"pmid":"15766656","id":"PMC_15766656","title":"RalGDS comes of age.","date":"2005","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/15766656","citation_count":19,"is_preprint":false},{"pmid":"27460202","id":"PMC_27460202","title":"RGDS- and SIKVAVS-Modified Superporous Poly(2-hydroxyethyl methacrylate) Scaffolds for Tissue Engineering Applications.","date":"2016","source":"Macromolecular bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/27460202","citation_count":18,"is_preprint":false},{"pmid":"28744424","id":"PMC_28744424","title":"Single-molecule fluorescence imaging of RalGDS on cell surfaces during signal transduction from Ras to Ral.","date":"2017","source":"Biophysics and physicobiology","url":"https://pubmed.ncbi.nlm.nih.gov/28744424","citation_count":18,"is_preprint":false},{"pmid":"8222396","id":"PMC_8222396","title":"Inhibition of tumor metastasis by Arg-Gly-Asp-Ser (RGDS) peptide conjugated with sulfated chitin derivative, SCM-chitin-RGDS.","date":"1993","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/8222396","citation_count":18,"is_preprint":false},{"pmid":"26469971","id":"PMC_26469971","title":"RILP suppresses invasion of breast cancer cells by modulating the activity of RalA through interaction with RalGDS.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/26469971","citation_count":18,"is_preprint":false},{"pmid":"23473774","id":"PMC_23473774","title":"RalGDS-dependent cardiomyocyte autophagy is required for load-induced ventricular hypertrophy.","date":"2013","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23473774","citation_count":18,"is_preprint":false},{"pmid":"9516482","id":"PMC_9516482","title":"Interactions of the amino acid residue at position 31 of the c-Ha-Ras protein with Raf-1 and RalGDS.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9516482","citation_count":17,"is_preprint":false},{"pmid":"20213214","id":"PMC_20213214","title":"Hydrogel cell patterning incorporating photocaged RGDS peptides.","date":"2010","source":"Biomedical microdevices","url":"https://pubmed.ncbi.nlm.nih.gov/20213214","citation_count":17,"is_preprint":false},{"pmid":"8787788","id":"PMC_8787788","title":"Antimetastatic activities of synthetic Arg-Gly-Asp-Ser (RGDS) and Arg-Leu-Asp-Ser (RLDS) peptide analogues and their inhibitory mechanisms.","date":"1995","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/8787788","citation_count":16,"is_preprint":false},{"pmid":"11432872","id":"PMC_11432872","title":"JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11432872","citation_count":16,"is_preprint":false},{"pmid":"25127074","id":"PMC_25127074","title":"Conserved electrostatic fields at the Ras-effector interface measured through vibrational Stark effect spectroscopy explain the difference in tilt angle in the Ras binding domains of Raf and RalGDS.","date":"2014","source":"Physical chemistry chemical physics : PCCP","url":"https://pubmed.ncbi.nlm.nih.gov/25127074","citation_count":16,"is_preprint":false},{"pmid":"25034103","id":"PMC_25034103","title":"The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.","date":"2013","source":"The Enzymes","url":"https://pubmed.ncbi.nlm.nih.gov/25034103","citation_count":15,"is_preprint":false},{"pmid":"1431231","id":"PMC_1431231","title":"Keratinocyte migration is partially supported by the cell-binding domain of fibronectin and is RGDS-dependent.","date":"1992","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/1431231","citation_count":15,"is_preprint":false},{"pmid":"12168089","id":"PMC_12168089","title":"Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.","date":"2002","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12168089","citation_count":15,"is_preprint":false},{"pmid":"22020461","id":"PMC_22020461","title":"RGDS-fuctionalized alginates improve the survival rate of encapsulated embryonic stem cells during cryopreservation.","date":"2011","source":"Cryo letters","url":"https://pubmed.ncbi.nlm.nih.gov/22020461","citation_count":15,"is_preprint":false},{"pmid":"11602241","id":"PMC_11602241","title":"High-pressure NMR study of the complex of a GTPase Rap1A with its effector RalGDS. A conformational switch in RalGDS revealed from non-linear pressure shifts.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11602241","citation_count":14,"is_preprint":false},{"pmid":"10760592","id":"PMC_10760592","title":"The human RGL (RalGDS-like) gene: cloning, expression analysis and genomic organization.","date":"2000","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10760592","citation_count":14,"is_preprint":false},{"pmid":"7524499","id":"PMC_7524499","title":"Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor.","date":"1994","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7524499","citation_count":13,"is_preprint":false},{"pmid":"9138073","id":"PMC_9138073","title":"Studies on tumor-promoting activity of polyethylene: inhibitory activity of metabolic cooperation on polyethylene surfaces is markedly decreased by surface modification with collagen but not with RGDS peptide.","date":"1997","source":"Journal of biomedical materials research","url":"https://pubmed.ncbi.nlm.nih.gov/9138073","citation_count":12,"is_preprint":false},{"pmid":"16199103","id":"PMC_16199103","title":"RGDS and DGEA-induced [Ca2+]i signalling in human dermal fibroblasts.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/16199103","citation_count":12,"is_preprint":false},{"pmid":"34948169","id":"PMC_34948169","title":"Evolution of RGF/GLV/CLEL Peptide Hormones and Their Roles in Land Plant Growth and Regulation.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34948169","citation_count":11,"is_preprint":false},{"pmid":"33513895","id":"PMC_33513895","title":"Design of RGDS Peptide-Immobilized Self-Assembling β-Strand Peptide from Barnacle Protein.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33513895","citation_count":11,"is_preprint":false},{"pmid":"31086367","id":"PMC_31086367","title":"Developmental fidelity is imposed by genetically separable RalGEF activities that mediate opposing signals.","date":"2019","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31086367","citation_count":11,"is_preprint":false},{"pmid":"32262925","id":"PMC_32262925","title":"RGDS covalently surfaced nanodiamond as a tumor targeting carrier of VEGF-siRNA: synthesis, characterization and bioassay.","date":"2015","source":"Journal of materials chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/32262925","citation_count":11,"is_preprint":false},{"pmid":"22452721","id":"PMC_22452721","title":"Synthetic RGDS peptide attenuates mechanical ventilation-induced lung injury in rats.","date":"2012","source":"Experimental lung research","url":"https://pubmed.ncbi.nlm.nih.gov/22452721","citation_count":11,"is_preprint":false},{"pmid":"28067833","id":"PMC_28067833","title":"Contribution of the RgfD Quorum Sensing Peptide to rgf Regulation and Host Cell Association in Group B Streptococcus.","date":"2017","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/28067833","citation_count":10,"is_preprint":false},{"pmid":"37198968","id":"PMC_37198968","title":"Functionalization of 3D printed polymeric bioresorbable stents with a dual cell-adhesive peptidic platform combining RGDS and YIGSR sequences.","date":"2023","source":"Biomaterials science","url":"https://pubmed.ncbi.nlm.nih.gov/37198968","citation_count":10,"is_preprint":false},{"pmid":"26301301","id":"PMC_26301301","title":"Preparation and Characterization of RGDS/Nanodiamond as a Vector for VEGF-siRNA Delivery.","date":"2015","source":"Journal of biomedical nanotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/26301301","citation_count":10,"is_preprint":false},{"pmid":"17904828","id":"PMC_17904828","title":"Physico-chemical and thermodynamic aspects of fibroblastic attachment on RGDS-modified chitosan membranes.","date":"2007","source":"Colloids and surfaces. B, Biointerfaces","url":"https://pubmed.ncbi.nlm.nih.gov/17904828","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49263,"output_tokens":6155,"usd":0.120057},"stage2":{"model":"claude-opus-4-6","input_tokens":9765,"output_tokens":3666,"usd":0.210712},"total_usd":0.330769,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"RALGDS interacts directly with the GTP-bound (active) form of Ras p21 through the effector loop of Ras, competing with NF1 and Raf for binding to the effector loop; it does not interact with the GDP-bound form or effector-loop mutants of Ras.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding with insect-cell-expressed proteins, co-immunoprecipitation, in vitro competition assay with NF1 GTPase-activating activity\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (yeast two-hybrid, in vitro binding, co-IP, competition assay) in a single foundational study; replicated by subsequent structural and biochemical studies\",\n      \"pmids\": [\"7935463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Protein kinase A (PKA) phosphorylates RalGDS (without altering its GDP/GTP exchange activity for Ral) and also phosphorylates Raf-1 (reducing Raf-1 affinity for Ras), thereby selectively shifting Ras signaling from Raf toward RalGDS; EGF-induced Ras–RalGDS interaction in COS cells requires an intact effector loop on Ras.\",\n      \"method\": \"In vitro kinase phosphorylation assay, co-immunoprecipitation in COS cells, GDP/GTP exchange assay, use of effector-loop mutant Ras (T35A), forskolin treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay combined with cell-based co-IP and exchange assays; multiple orthogonal methods in one study\",\n      \"pmids\": [\"8550624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RalGDS functions as an effector of Ras in cAMP-mediated (TSH-induced) growth stimulation in thyrocytes, downstream of Ras but independent of Raf-1/MEK; microinjection of dominant-negative RalA (which sequesters RalGDS family members) inhibited Ras- and cAMP-induced DNA synthesis.\",\n      \"method\": \"Yeast two-hybrid (identifies RalGDS as Ras effector-domain mutant V12G37 binding partner), co-immunoprecipitation in thyroid cell extracts, microinjection of dominant-negative RalA protein, DNA synthesis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus functional rescue by dominant-negative microinjection; multiple methods in one lab\",\n      \"pmids\": [\"9038168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The three-dimensional structure of the Ras-interacting domain (RID) of RalGDS was determined; mutational analysis identified three residues in the RID critical for interaction with Ras.\",\n      \"method\": \"NMR structure determination; site-directed mutagenesis of RID residues, binding assays\",\n      \"journal\": \"Nature structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with mutagenesis validation\",\n      \"pmids\": [\"9253406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Crystal structure of the Ras–RalGDS RID complex at 2.1 Å resolution revealed that the beta-sheet of the RID joins the switch I region of Ras to form an extended beta-sheet, and a second RID molecule contacts the switch II region of Ras, explaining cross-talk between Ras and Ral pathways and effector specificity.\",\n      \"method\": \"X-ray crystallography at 2.1 Å resolution\",\n      \"journal\": \"Nature structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with functional interpretation\",\n      \"pmids\": [\"9628477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"RalGDS (via a membrane-targeted CAAX construct) inhibits skeletal myogenesis independently of Raf, acting on SRF-dependent transcription; however, a Ras effector-loop mutant that retains RalGDS interaction (H-Ras G12V,E37G) also inhibits an SRF-independent myogenic reporter, indicating an additional Ras effector beyond RalGDS is required for full myogenic inhibition.\",\n      \"method\": \"Expression of constitutively active and dominant-negative constructs, luciferase reporter assays for muscle-specific promoters (alpha-actin-Luc, troponin I-Luc), co-expression in C3H10T1/2 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic and reporter assays; single lab but multiple constructs and reporters\",\n      \"pmids\": [\"9651367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"X-ray crystal structure of the Ras–RalGDS RBD complex confirmed inter-protein beta-sheet interaction via switch I; mutational analysis of interface residues quantified their contribution to binding affinity; gel filtration showed the complex is monomeric.\",\n      \"method\": \"X-ray crystallography, site-directed mutagenesis, gel filtration\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus mutagenesis and biophysical validation\",\n      \"pmids\": [\"10371160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"In C. elegans, the RalGEF ortholog (Rlf/RGL-1) is required for Ras-induced primitive endoderm differentiation of F9 embryonal carcinoma cells; constitutively active RalGEF (Rlf-CAAX) is sufficient to induce differentiation in a Ral-dependent manner that also requires basal MEK/ERK activity.\",\n      \"method\": \"Expression of constitutively active Rlf-CAAX and dominant-negative Ral, inhibitor of MEK (PD98059), differentiation morphology assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with dominant-negative and constitutively active constructs; single lab\",\n      \"pmids\": [\"10442634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The Ras-binding domain (RBD) of RalGDS is important but not sufficient for Ras-stimulated Ral activation; an artificially membrane-targeted RalGDS lacking its RBD can still be activated by Ras via its switch II region (Y64W mutation in Ras impairs this). Rap1 blocks Ras-mediated RalGDS signaling only when RalGDS contains an intact RBD (by forming a long-lived competing complex), explaining Rap1 antagonism.\",\n      \"method\": \"In vivo Ral-GTP loading assay, point-mutation analysis (RBD-defective RalGDS, CAAX membrane targeting, Ras Y64W), kinetic analysis of complex formation by stopped-flow fluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinetic assays combined with cell-based Ral-GTP loading and multiple mutant analyses; multiple orthogonal methods\",\n      \"pmids\": [\"11748241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"JAK/STAT3 pathway activation induces RalGDS expression, and RalGDS expression leads to RalA activation in M1 myeloid leukemia cells; full RalA activation also requires Ras activity, revealing cross-talk between JAK/STAT3 and Ras/RalGDS/Ral pathways.\",\n      \"method\": \"Representational difference analysis to clone RalGDS, dominant-negative STAT3 expression, JAK inhibitor (JAB/SOCS1), Ras inhibitor, Ral-GTP pull-down assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with dominant-negatives and inhibitors plus Ral-GTP pull-down; single lab\",\n      \"pmids\": [\"11432872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Beta-arrestins bind RalGDS and maintain it in an inactive cytosolic complex; upon fMLP receptor stimulation, beta-arrestin–RalGDS complexes dissociate and both translocate to the plasma membrane, activating Ral signaling in a Ras-independent manner to mediate cytoskeletal reorganization; re-association of the complex inactivates Ral signaling.\",\n      \"method\": \"Yeast two-hybrid screening, co-immunoprecipitation from PMNs, subcellular fractionation/translocation assays, Ral-GTP activation assay\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by reciprocal co-IP from primary cells, translocation experiments with functional readout; multiple orthogonal methods\",\n      \"pmids\": [\"12105416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PDK1 enhances RalGDS catalytic (GEF) activity in a kinase-independent manner: the non-catalytic N-terminus of PDK1 forms an EGF-induced complex with the N-terminus of RalGDS, relieving its autoinhibitory effect on the catalytic domain, thereby providing a second mechanism (beyond Ras-mediated membrane redistribution) for Ral-GEF activation.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative PDK1 kinase-dead mutant, deletion mapping of PDK1–RalGDS interaction domains, in vivo Ral-GTP assay, EGF stimulation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — kinase-dead mutant distinguishes catalytic from scaffolding function; domain mapping plus functional GTP-loading assay; multiple methods\",\n      \"pmids\": [\"11889038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"RalGDS mediates Ras-dependent activation of ATF2 Thr69 phosphorylation via a RalGDS–Src–p38 pathway, while Raf–MEK–ERK phosphorylates ATF2 Thr71; cooperation of both pathways is required for full ATF2 activation by growth factors.\",\n      \"method\": \"Ras effector-loop mutants (G12V/G37 selectively activates RalGEF path), dominant-negative constructs, phospho-specific antibodies for ATF2 Thr69/Thr71, in vivo kinase assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with well-characterized effector-loop mutants plus quantitative phosphorylation readout; independently consistent with known pathway\",\n      \"pmids\": [\"12110590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"RalGDS and PI3K (but not Raf) mediate Ras-dependent activation of choline kinase; RalGDS and PI3K also provide opposing regulatory inputs to phospholipase D downstream of oncogenic Ras.\",\n      \"method\": \"Ras effector-domain mutants (G12V/S35 Raf-only, G12V/C40 PI3K-only, G12V/G37 RalGEF-only), choline kinase activity assay, phospholipase D activity assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — well-validated effector-domain mutant approach; single lab but two different enzymatic readouts\",\n      \"pmids\": [\"11840339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The Ras/RalGEF/p38 pathway is required for reovirus oncolysis: Ras mutant V12G37 (which signals only through RalGEFs) supports reovirus infection; dominant-negative RalA blocks infection; chemical inhibition of p38 (but not JNK) prevents reovirus replication in Ras-transformed cells.\",\n      \"method\": \"NIH 3T3 cells expressing Ras effector-domain mutants, activated RalGEF (Rlf) expression, dominant-negative RalA, p38 and JNK chemical inhibitors, reovirus replication assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via effector-domain mutants, dominant-negative, and pharmacological inhibitors with clear viral replication readout\",\n      \"pmids\": [\"15263068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RalGDS mediates Ras-induced upregulation of ST6Gal I (beta-galactoside alpha2,6-sialyltransferase) via the RalGEF signal, specifically through the housekeeping promoter P3; this was shown using Ras effector-domain mutants that selectively activate individual Ras pathways.\",\n      \"method\": \"Ras effector-domain mutants (H-RasV12S35, H-RasV12C40, H-RasV12G37), RT-PCR, sialyltransferase activity assay, 5'-RACE, inducible H-RasV12 expression system\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — selective effector-domain mutants with multiple readouts (mRNA, enzyme activity, cell-surface glycan); single lab\",\n      \"pmids\": [\"15355339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RalGDS knockout mice are viable and develop normally but show markedly reduced tumor incidence, size, and malignant progression in Ras-driven multistage skin carcinogenesis; RalGDS controls survival (via the JNK/SAPK pathway) rather than proliferation of transformed cells.\",\n      \"method\": \"Ralgds knockout mice, DMBA/TPA skin carcinogenesis model, cell proliferation assays, cell survival/apoptosis assays, JNK/SAPK pathway analysis in tumor-derived cells\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic KO with well-defined tumor phenotype and pathway analysis; strong evidence from a landmark study\",\n      \"pmids\": [\"15766660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Activation of the RalGEF pathway (but not Raf/ERK or PI3K) promotes prostate cancer bone metastasis; loss of RalA in metastatic PC3 cells inhibits bone metastasis but not subcutaneous tumor growth, implicating Ral-dependent expansion in the bone microenvironment.\",\n      \"method\": \"Ras effector-domain mutants expressed in DU145 cells, in vivo bone metastasis model, RalA shRNA knockdown in PC3 cells, intracardiac injection metastasis assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo epistasis with effector-domain mutants and RalA knockdown; clear organ-specific metastasis readout\",\n      \"pmids\": [\"17709381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RalGDS promotes Akt phosphorylation by PDK1 through a second, GEF-independent scaffolding function: RalGDS brings PDK1 (via its N-terminus) and Akt (via its central region, through intermediary JIP1) together; suppression of RalGDS blocks EGF- and insulin-induced Akt phosphorylation and inhibits cell proliferation.\",\n      \"method\": \"Co-immunoprecipitation, RNAi knockdown of RalGDS, deletion mutants of RalGDS separating GEF activity from Akt activation, phospho-Akt immunoblot, proliferation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain separation mutants plus RNAi with two orthogonal functional readouts (phospho-Akt and proliferation); single lab but rigorous\",\n      \"pmids\": [\"18285454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RalGDS mediates exocytosis of Weibel-Palade bodies (WPBs) from endothelial cells: RNAi knockdown of RalGDS inhibits thrombin- and epinephrine-induced WPB exocytosis; overexpression promotes it; a GEF-dead RalGDS acts as dominant negative. RalGDS binds calmodulin (CaM) via an N-terminal CaM-binding domain, and this CaM association is required for Ral activation and WPB exocytosis.\",\n      \"method\": \"RNAi knockdown, overexpression, dominant-negative GEF-dead RalGDS, cell-permeable CaM-binding domain peptide, Ral-GTP pull-down, WPB exocytosis (VWF release) assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic manipulations (RNAi, OE, dominant-negative) with clear functional readout plus identification of calmodulin as binding partner by peptide inhibitor\",\n      \"pmids\": [\"18417737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RalGDS-null cardiomyocytes show impaired load-induced autophagy and blunted hypertrophic growth in response to pressure overload (TAC); specifically RalB (downstream of RalGDS) is required for mTOR-dependent cardiomyocyte autophagy, linking RalGDS to exocyst-dependent membrane trafficking in cardiac remodeling.\",\n      \"method\": \"Ralgds knockout mice, TAC pressure-overload model, RalA/RalB siRNA knockdown in neonatal rat cardiomyocytes, autophagy markers (LC3, beclin), echocardiography\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO plus cell-based siRNA with defined autophagy readout; single lab\",\n      \"pmids\": [\"23473774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RILP (Rab7-interacting lysosomal protein) interacts with the GEF domain of RalGDS through RILP's N-terminal region, recruits RalGDS to late endosomal compartments, and inhibits RalGDS GEF activity toward RalA, thereby suppressing breast cancer cell invasion.\",\n      \"method\": \"Co-immunoprecipitation, truncation/domain mapping, immunofluorescence microscopy, RalA-GTP pull-down, Matrigel invasion assay, RNAi knockdown\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with domain mapping plus subcellular localization and functional GEF-activity assay; single lab\",\n      \"pmids\": [\"26469971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Single-molecule fluorescence imaging showed that RalGDS translocates from the cytoplasm to the plasma membrane upon EGF-induced Ras activation via its RBD (not the REMCDC catalytic domain); the REMCDC domain reduces the dissociation rate from the membrane after Ras activation or Ral hyperexpression; RalGDS clusters at the membrane and the Y64 residue of Ras participates in stabilizing the RalGDS–membrane interaction.\",\n      \"method\": \"Single-molecule total internal reflection fluorescence (TIRF) microscopy in living HeLa cells, EGF stimulation, domain deletion mutants (RBD vs. REMCDC), kinetic analysis of membrane association/dissociation\",\n      \"journal\": \"Biophysics and physicobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct single-molecule localization with functional domain analysis; single lab but novel orthogonal method\",\n      \"pmids\": [\"28744424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In C. elegans, the RalGDS ortholog RGL-1 has two genetically separable activities: a canonical GEF-dependent activity that activates RAL-1 to promote 2° vulval cell fate, and a non-canonical GEF-independent activity that promotes 1° fate via the PI3K-PDK-1-AKT cascade; these opposing activities reduce developmental stochasticity.\",\n      \"method\": \"C. elegans genetics, RGL-1 deletion and domain mutants, epistasis with dominant-negative and activated pathway components, vulval cell fate scoring\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — rigorous genetic epistasis in a model organism; C. elegans ortholog with conserved domain architecture\",\n      \"pmids\": [\"31086367\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RALGDS is a Ras effector and guanine nucleotide exchange factor (GEF) for Ral GTPases (RalA and RalB): upon growth factor stimulation, GTP-loaded Ras binds the RBD of RALGDS (via an inter-protein beta-sheet with Ras switch I, as revealed by crystal structures), recruiting RALGDS to the plasma membrane and relieving autoinhibition of its CDC25 catalytic domain; PDK1 further enhances RALGDS GEF activity through a kinase-independent scaffolding interaction; beta-arrestins additionally regulate RALGDS by sequestering it in the cytosol and chaperoning its membrane translocation; activated Ral then drives cytoskeletal reorganization, Weibel-Palade body exocytosis, autophagy, and stress-kinase (JNK/p38) signaling, while RALGDS also scaffolds PDK1–Akt to promote cell survival, making it a multifunctional node in Ras-dependent oncogenesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RALGDS is a guanine nucleotide exchange factor (GEF) for Ral GTPases (RalA and RalB) and a direct effector of Ras, serving as a critical signaling node that translates Ras activation into cytoskeletal reorganization, regulated exocytosis, autophagy, stress-kinase signaling, and cell survival. GTP-loaded Ras recruits RALGDS to the plasma membrane through an inter-protein β-sheet interaction between Ras switch I and the RALGDS Ras-binding domain (RBD), while PDK1 relieves autoinhibition of the catalytic CDC25 domain in a kinase-independent manner, and beta-arrestins regulate RALGDS cytosol-to-membrane translocation upon GPCR stimulation [PMID:9628477, PMID:11889038, PMID:12105416]. Beyond its GEF activity, RALGDS scaffolds PDK1 and Akt (via JIP1) to promote Akt phosphorylation and cell survival independently of Ral exchange, and signals through Ral to JNK/p38 and Src to control ATF2 phosphorylation and tumor cell survival [PMID:18285454, PMID:12110590, PMID:15766660]. RALGDS knockout mice are viable but show markedly reduced Ras-driven tumor incidence and impaired load-induced cardiac autophagy, establishing RALGDS as essential for Ras-dependent oncogenesis and stress-responsive membrane trafficking in vivo [PMID:15766660, PMID:23473774].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing that RALGDS is a direct, GTP-dependent effector of Ras resolved how the Ral-GEF pathway connects to the canonical Ras switch and competes with Raf and NF1 for the Ras effector loop.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding, co-immunoprecipitation, and NF1-competition assay with insect-cell-expressed proteins\",\n      \"pmids\": [\"7935463\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the Ras–RalGDS interaction was unknown\", \"In vivo relevance of the Ras–RalGDS axis was not yet tested\", \"How GEF activity is regulated beyond Ras binding was unclear\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Demonstration that PKA phosphorylates Raf-1 to reduce its Ras affinity without affecting RalGDS exchange activity revealed a signal-switching mechanism that reroutes Ras output from Raf toward RalGDS under cAMP-elevating conditions.\",\n      \"evidence\": \"In vitro kinase assay, co-immunoprecipitation in COS cells, GDP/GTP exchange assay, Ras T35A effector-loop mutant, forskolin treatment\",\n      \"pmids\": [\"8550624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKA-mediated pathway switching operates in physiological tissues was untested\", \"Direct phosphorylation sites on RalGDS were not mapped\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"NMR structure of the RalGDS Ras-interacting domain and demonstration that RalGDS mediates Ras-dependent, Raf-independent proliferation in thyrocytes established the structural and functional autonomy of the Ras–RalGDS arm.\",\n      \"evidence\": \"NMR structure determination with mutagenesis; dominant-negative RalA microinjection blocking cAMP/Ras-induced DNA synthesis in thyroid cells\",\n      \"pmids\": [\"9253406\", \"9038168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full atomic detail of the Ras–RalGDS complex was still lacking\", \"Downstream targets of RalA activation in this context were unidentified\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Crystal structures of the Ras–RalGDS RBD complex at 2.1 Å revealed an inter-protein β-sheet mediated by Ras switch I, providing the atomic framework for understanding effector selectivity among Ras targets.\",\n      \"evidence\": \"X-ray crystallography at 2.1 Å resolution, confirmed by independent structure with mutagenesis and gel filtration (1999)\",\n      \"pmids\": [\"9628477\", \"10371160\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the catalytic CDC25 domain is autoinhibited and activated was unresolved\", \"Role of the Ras switch II contact observed in the crystal remained functionally untested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Dissection of RBD-dependent versus RBD-independent activation mechanisms showed that membrane recruitment via the RBD is important but not sufficient, and that Rap1 antagonizes RalGDS by sequestering the RBD in a kinetically trapped complex, resolving a long-standing question about Rap1–Ras cross-talk.\",\n      \"evidence\": \"In vivo Ral-GTP loading with RBD-defective/CAAX-targeted RalGDS, Ras Y64W mutant, stopped-flow fluorescence kinetics\",\n      \"pmids\": [\"11748241\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the non-RBD Ras contact site on RalGDS was not mapped\", \"Whether Rap1 antagonism operates in vivo was unconfirmed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Multiple studies in 2002 established that RalGDS integrates diverse regulatory inputs (PDK1 scaffolding, beta-arrestin sequestration) and diverse outputs (ATF2 via Src/p38, choline kinase, Ral-driven cytoskeletal reorganization), positioning it as a multifunctional signaling hub rather than a simple Ras-to-Ral relay.\",\n      \"evidence\": \"PDK1 kinase-dead mutant co-IP and domain mapping with Ral-GTP assay; beta-arrestin yeast two-hybrid, co-IP from PMNs, translocation assays; Ras effector-domain mutant epistasis for ATF2 phosphorylation and choline kinase activity\",\n      \"pmids\": [\"11889038\", \"12105416\", \"12110590\", \"11840339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PDK1 scaffolding and beta-arrestin regulation converge on the same pool of RalGDS was unknown\", \"Structural basis of autoinhibition relief by PDK1 was not determined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"RALGDS knockout mice showed reduced tumor incidence and impaired JNK-dependent survival of transformed cells in a Ras-driven carcinogenesis model, providing the first in vivo genetic proof that RALGDS is essential for Ras-mediated oncogenesis.\",\n      \"evidence\": \"Ralgds-null mice subjected to DMBA/TPA multistage skin carcinogenesis, with tumor burden quantification, apoptosis assays, and JNK pathway analysis\",\n      \"pmids\": [\"15766660\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RalGDS is required for tumor maintenance versus initiation was not distinguished\", \"Contribution of individual Ral isoforms (RalA vs RalB) in vivo was not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The RalGEF pathway was shown to specifically promote bone metastasis of prostate cancer cells through RalA, distinct from subcutaneous tumor growth, establishing tissue-microenvironment specificity for RalGDS signaling.\",\n      \"evidence\": \"Ras effector-domain mutants in DU145 cells, RalA shRNA in PC3 cells, intracardiac injection metastasis model\",\n      \"pmids\": [\"17709381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Bone microenvironment signals activating RalGDS were not identified\", \"Whether RalB also contributes to metastasis in this model was not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery that RALGDS scaffolds PDK1 and Akt (via JIP1) to promote Akt phosphorylation independently of its GEF activity, and that it drives Weibel-Palade body exocytosis through calmodulin-dependent Ral activation, revealed two additional non-canonical functions separable from Ral exchange.\",\n      \"evidence\": \"Domain-separation mutants and RNAi for PDK1–Akt scaffolding with phospho-Akt readout; RNAi, dominant-negative GEF-dead RalGDS, CaM-binding domain peptide for WPB exocytosis (VWF release)\",\n      \"pmids\": [\"18285454\", \"18417737\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether JIP1 is the sole mediator of Akt recruitment was not confirmed\", \"Calmodulin-binding site on RalGDS was mapped only by peptide competition, not structurally\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"RALGDS-null cardiomyocytes showed impaired autophagy and blunted hypertrophic growth under pressure overload, linking RALGDS–RalB signaling to mTOR-dependent autophagy and cardiac stress adaptation beyond oncogenesis.\",\n      \"evidence\": \"Ralgds knockout mice with TAC pressure-overload, RalA/RalB siRNA in neonatal cardiomyocytes, autophagy markers (LC3, beclin), echocardiography\",\n      \"pmids\": [\"23473774\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Exocyst-dependent membrane trafficking mechanism in cardiomyocytes was inferred but not directly demonstrated\", \"Whether RalGDS GEF or scaffolding activity mediates the cardiac phenotype was not distinguished\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"RILP was identified as a negative regulator that recruits RalGDS to late endosomes and inhibits its GEF activity, suppressing RalA-dependent breast cancer cell invasion and revealing compartment-specific regulation of RalGDS.\",\n      \"evidence\": \"Co-immunoprecipitation, domain mapping, immunofluorescence, RalA-GTP pull-down, Matrigel invasion assay\",\n      \"pmids\": [\"26469971\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether RILP-mediated endosomal sequestration operates in non-transformed cells was not tested\", \"Structural basis of RILP inhibition of the GEF domain was not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Single-molecule imaging directly visualized RalGDS membrane recruitment kinetics, showing that the RBD mediates initial Ras-dependent translocation while the REMCDC catalytic domain reduces dissociation rate, providing a biophysical framework for two-step membrane engagement.\",\n      \"evidence\": \"Single-molecule TIRF microscopy in living HeLa cells with domain deletion mutants and EGF stimulation\",\n      \"pmids\": [\"28744424\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether membrane clustering reflects oligomerization or lipid-domain partitioning was not resolved\", \"Kinetic measurements were in a single overexpression system\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Genetic analysis in C. elegans demonstrated that the RalGDS ortholog RGL-1 has genetically separable GEF-dependent (promoting Ral-mediated 2° fate) and GEF-independent (promoting PI3K–PDK-1–AKT-mediated 1° fate) activities, confirming evolutionary conservation of dual signaling modes.\",\n      \"evidence\": \"C. elegans RGL-1 deletion and domain mutants, genetic epistasis with pathway components, vulval fate scoring\",\n      \"pmids\": [\"31086367\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the mammalian GEF-independent PDK1–Akt scaffolding function is fully orthologous to the worm pathway was not tested\", \"Direct biochemical interaction between RGL-1 and worm PDK-1 was not demonstrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A full structural model of autoinhibited full-length RALGDS, the conformational change upon PDK1 or Ras engagement, and the relative quantitative contributions of GEF-dependent versus scaffolding functions in specific disease contexts remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length RALGDS structure exists\", \"Quantitative partitioning of GEF versus scaffolding functions in vivo is unknown\", \"Whether therapeutic targeting of the RBD–Ras interface is feasible has not been explored structurally\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 8, 11, 19]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [18, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10, 22]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [10, 22]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 4, 8, 11, 12]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [16, 17]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HRAS\", \"RALA\", \"RALB\", \"PDPK1\", \"ARRB1\", \"ARRB2\", \"RILP\", \"CALM1\"],\n    \"other_free_text\": []\n  }\n}\n```"}